yakuken
Substacknewsletter · by yakuken
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Weekly
- From 5 posts indexed in the last 90 days
- Last post
- Nov 7, 2026
- 11 days ago
- Likely audience
- 投資家
- Inferred from post content
yakuken is a Substack newsletter by yakuken covering Biotech stock analysis, FDA approval event and AstraZeneca investment. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Nov 7, 2026.
Topics
- Biotech stock analysis
- FDA approval event
- AstraZeneca investment
- Clinical trial results
Recent posts
- 【第一三共】利益47%増…
- 好決算の製薬株3社、どこ…
- 【米国バイオ銘柄】株価が…
- 【今週末に確認したい】1…
- 【暴落3社】今が買い場?
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on yakuken
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
yakuken alternatives: similar newsletters
Ranked by how many topics they share with yakuken.
- Dr. Michael Okun on Parkinson's & Brain Health11K subscribers
SubstackMonthly or less · last post 4 days ago
Likely audience: Patients with Parkinson's disease
1 shared topic
- Healthcare Stock Ideas3K subscribers
SubstackEvery two weeks · last post 18 days ago
Likely audience: investors
1 shared topic
- Michael Halassa2K subscribers
SubstackEvery two weeks · last post 26 days ago
Likely audience: cognitive scientists
1 shared topic
LinkedInEvery two weeks · last post 26 days ago
Likely audience: Healthcare investors
1 shared topic
LinkedInEvery two weeks · last post 20 days ago
Likely audience: Pharmaceutical executives
1 shared topic
SubstackMonthly or less · last post Sep 3, 2026
Likely audience: Biotech investors
1 shared topic
Compiled from public pages · refreshed Nov 10, 2026 · How NewsletterFIT collects and labels data
